Bayer CropScience Ltd Stock Analysis

BSE: 506285 | NSE: BAYERCROP | Pesticides & Agrochemicals | Small Cap

BSE Share Price 30-Nov-2023 17:59
5375.40 142.70 (2.73%)

DeciZen - Make an Informed Decision on Bayer CropScience

Overall Rating

1. Quality

2. Valuation


3. Price Trend

Semi Strong

Bayer CropScience Price Chart

P/E Ratio (SA):
Market Cap:
24,158.2 Cr.
52-wk low:
52-wk high:
Bole Toh?

1. Is Bayer CropScience Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bayer CropScience Ltd is a good quality company.

2. Is Bayer CropScience Ltd undervalued or overvalued?

The key valuation ratios of Bayer CropScience Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Bayer CropScience Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Bayer CropScience Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bayer CropScience:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bayer CropScience Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 16.2%20.6%16.8%15.3%16.3%17.4%23.7%19.1%23.9%26.5%-
Value Creation Index

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3,2453,7232,7692,8032,7103,1673,6094,2614,7345,1405,377
YoY Gr. Rt. %-14.7%-25.6%1.2%-3.3%16.9%14%18.1%11.1%8.6%-
Adj EPS 80.2105.289.883.288.599.7124.9106.8133.1150.8187.9
YoY Gr. Rt. %-31.1%-14.6%-7.4%6.4%12.6%25.3%-14.5%24.7%13.3%-
BVPS (₹) 476555.4519.6581518.5649.8572.9568562.2604696.8
Adj Net Profit 294385317294304342561480598678844
Cash Flow from Ops. 282200207157121433666687216609-
Debt/CF from Ops. 0000000000-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.2%13.7%12.5%8.6%
Adj EPS 7.3%11.3%6.5%13.3%
Share Price 12.4% 4.7% 2.2% 16.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 1620.416.415.115.81723.318.723.625.928.9
Op. Profit Mgn % 12.713.915.814.915.315.420.21917.117.919
Net Profit Mgn % 9.110.311.510.511.210.815.611.312.613.215.7
Debt to Equity 00000000000
Working Cap Days 244238326357439411389345349359248
Cash Conv. Cycle 636510111013110181747787139

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 28.90%

Sales growth is growing at healthy rate in last 3 years 12.50%

Net Profit has been subdued in last 3 years 6.48%

Sales growth is not so good in last 4 quarters at 5.64%

Latest Financials - Bayer CropScience Ltd.

Standalone Consolidated
TTM EPS (₹) 187.9 12.3
TTM Sales (₹ Cr.) 5,377 783
BVPS (₹.) 696.8 0
Reserves (₹ Cr.) 3,087 294
P/BV 7.71 0.00
PE 28.61 436.00
From the Market
52 Week Low / High (₹) 3922.45 / 5619.00
All Time Low / High (₹) 34.13 / 6550.00
Market Cap (₹ Cr.) 24,158
Equity (₹ Cr.) 44.9
Face Value (₹) 10
Industry PE 34.2

Management X-Ray of Bayer CropScience :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bayer CropScience

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Bayer CropScience Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bayer CropScience on 30-Nov-2023 17:59 is : 5,375.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 30-Nov-2023 17:59 the market cap of Bayer CropScience stood at ₹ 24,158.2.
The latest PE ratio of Bayer CropScience as of 30-Nov-2023 17:59 is 28.61.
The latest PB ratio of Bayer CropScience as of 30-Nov-2023 17:59 is 7.71
The 52-week high of Bayer CropScience is ₹ 5,619 and the 52-week low is ₹ 3,922.5.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Bayer CropScience is ₹ 5,377 ( Cr.) .

About Bayer CropScience Ltd

Bayer CropScience is the flagship company of the Bayer Group in India and is publicly listed on the Bombay Stock Exchange. It is engaged in manufacturing of crop protection products, non agricultural pest-control, seeds and plant biotechnology. The company enjoys a unique position in the market because of its capability to offer new innovative products, technologies, processes, services and business models. With its innovative products, it is contributing to finding solutions to some of the major challenges of its time. The company remains committed to improving lives by advancing nutrition and healthcare solutions for the country’s growing population.

Business area of the company

The company’s Crop Science division is the largest for Bayer in India with businesses in seeds & traits, crop protection, digital farming and environmental science (non-agricultural pest control). Its robust crop protection portfolio includes products to manage insects, pests, weeds and diseases. It also includes bilogical solutions, that use nature’s own defenses to protect crops. Its broad range of high-quality hybrid seeds includes cutting-edge traits for high-yielding crops with improved weed management and superior insect control. Its expertise and innovations in digital farming provide farmers with a deeper understanding of their fields so they can utilize their inputs and natural resources as efficiently as possible. The company also has products that focus on non-agricultural applications in the form of products and services for vector control and professional pest control.

The company’s Pharmaceuticals division in India operates as Bayer Zydus Pharma, a joint venture between Bayer and Zydus Cadila. The focus of this business is on prescription products, especially for cardiology and women’s health care and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents. Its Consumer Health division is focused on making self-care for a better life a reality for billions of people around the world through everyday healthcare. Its Animal Health business develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.


  • Bayer India wins ‘Aon Best Employer in India 2017’ award.
  • Bayer India wins ‘Aon Best Employer in India 2018’ award.
  • Bayer India wins the Mercer NDTV Employer Excellence Award 2018.
  • Bayer India wins ‘Aon Best Employer in India 2019’ award for the third time in a row.
  • Bayer received a 'Great Places to Work' certification.


  • 1863: The company is founded on August 1, 1863 by dye salesman Friedrich Bayer and the master dyer Johann Friedrich Weskott in Wuppertal, Germany - a 19th century startup with tremendous potential.
  • 1896: First wholly-owned subsidiary of Bayer in Asia ‘Farbenfabriken Bayer and Company Limited’ is set-up in Mumbai.
  • 1958: Bayer CropScience Ltd. – the listed entity for Bayer in India - was incorporated on September 9, 1958.
  • 1958: Bayer establishes Bayer Agrochem Private Limited in India.
  • 1963: The name of Bayer Agrochem changes to Bayer (India) Limited.
  • 1969: The company commences operations of a major plant in Thane.
  • 2001: Bayer acquires Aventis CropScience.
  • 2004: First Imidacloprid production facility outside Germany is inaugurated in Vapi.
  • 2005: Lanxess AG is spun off from the Bayer Group.
  • 2006: Takeover of Schering AG, Berlin, Germany.
  • 2011: Bayer Zydus Pharma is set up as a 50:50 joint venture between Bayer HealthCare and Zydus Cadilla.
  • 2013: The Seeds business unit (Bayer BioScience) of Bayer CropScience, India opens a multi-crop breeding station in Chandippa, near Hyderabad and a Mustard Breeding Station in Palwal, Haryana.
  • 2014: New Headquarters of Bayer South Asia inaugurated at Thane.
  • 2015: Bayer MaterialScience is now independent under the name Covestro.
  • 2016: In September, Bayer and Monsanto sign a binding merger agreement.
  • 2017: Bayer kicks off ‘LEAPS‘ globally as a new approach to complement the existing R&D capabilities and which aims to enable breakthrough innovations across healthcare and agriculture.
  • 2018: Bayer concludes process to sell Covestro.
  • 2019: Bayer completes Monsanto integration in India in September.
  • 2019: A new plant is inaugurated at Bayer‘s Himatnagar site, strengthening company’s manufacturing footprint in Gujarat.
  • 2020: FOGSI and Bayer Zydus Pharma collaborate to drive adoption of digital technology solution ‘Ask Tanu’.
  • 2020: Bayer’s Aflibercept injection (EyleaTM) for intravitreal use receives DCGI Approval for Diabetic Macular Edema Indication.
  • 2020: Bayer partners with ITC e-Choupal 4.0 to support farmers.
  • 2020: Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now